Tae-Jin Song1, Jinkwon Kim1, Dongbeom Song1, Hyo Suk Nam1, Young Dae Kim1, Hye Sun Lee1, Ji Hoe Heo2. 1. From the Departments of Neurology (T.-J.S., D.S., H.S.N., Y.D.K., J.H.H.) and Biostatistics (H.S.L.), Yonsei University College of Medicine, Seoul; Department of Neurology (T.-J.S.), Ewha Womans University School of Medicine, Seoul; and Department of Neurology (J.K.), CHA Bundang Medical Centre, CHA University, Seongnam, Korea. 2. From the Departments of Neurology (T.-J.S., D.S., H.S.N., Y.D.K., J.H.H.) and Biostatistics (H.S.L.), Yonsei University College of Medicine, Seoul; Department of Neurology (T.-J.S.), Ewha Womans University School of Medicine, Seoul; and Department of Neurology (J.K.), CHA Bundang Medical Centre, CHA University, Seongnam, Korea. jhheo@yuhs.ac.
Abstract
OBJECTIVES: We investigated the association of cerebral microbleeds (CMBs) with long-term mortality in patients with nonvalvular atrial fibrillation (NVAF) according to burden and distribution of CMBs. METHODS: This was a retrospective, hospital-based, observational study. In total, 504 consecutive ischemic stroke patients with NVAF who underwent brain T2-weighted, gradient-recalled echo MRI were included. Data for the date and causes of death were based on the death certificates from the Korean National Statistical Office. We determined the association of the presence, burden, and distribution of CMBs with mortality from all-cause, ischemic heart disease, ischemic stroke, and hemorrhagic stroke. RESULTS: CMBs were found in 30.7% of patients (155/504). During a median follow-up of 2.5 years, 176 patients (34.9%) died (ischemic stroke, 81; hemorrhagic stroke, 12; ischemic heart disease, 32). Patients with CMBs died more frequently than those without (41.9% vs 31.8%, p = 0.028). After adjusting for age, sex, and other significant variables, the presence of multiple (≥5) CMBs was as an independent predictor for all-cause (hazard ratio [HR]: 1.99) and ischemic stroke (HR: 3.39) mortality. Patients with strictly lobar CMBs had an increased risk of hemorrhagic stroke mortality (HR: 5.91). CONCLUSIONS: The presence and burden of CMBs were associated with increased mortality in stroke patients with NVAF. Patients with lobar CMBs were at increased risk of death due to hemorrhagic stroke. The diagnosis of CMBs is of value in predicting long-term prognosis in stroke patients with NVAF.
OBJECTIVES: We investigated the association of cerebral microbleeds (CMBs) with long-term mortality in patients with nonvalvular atrial fibrillation (NVAF) according to burden and distribution of CMBs. METHODS: This was a retrospective, hospital-based, observational study. In total, 504 consecutive ischemic strokepatients with NVAF who underwent brain T2-weighted, gradient-recalled echo MRI were included. Data for the date and causes of death were based on the death certificates from the Korean National Statistical Office. We determined the association of the presence, burden, and distribution of CMBs with mortality from all-cause, ischemic heart disease, ischemic stroke, and hemorrhagic stroke. RESULTS:CMBs were found in 30.7% of patients (155/504). During a median follow-up of 2.5 years, 176 patients (34.9%) died (ischemic stroke, 81; hemorrhagic stroke, 12; ischemic heart disease, 32). Patients with CMBs died more frequently than those without (41.9% vs 31.8%, p = 0.028). After adjusting for age, sex, and other significant variables, the presence of multiple (≥5) CMBs was as an independent predictor for all-cause (hazard ratio [HR]: 1.99) and ischemic stroke (HR: 3.39) mortality. Patients with strictly lobar CMBs had an increased risk of hemorrhagic stroke mortality (HR: 5.91). CONCLUSIONS: The presence and burden of CMBs were associated with increased mortality in strokepatients with NVAF. Patients with lobar CMBs were at increased risk of death due to hemorrhagic stroke. The diagnosis of CMBs is of value in predicting long-term prognosis in strokepatients with NVAF.
Authors: Malini Madhavan; Tiffany Y Hu; Bernard J Gersh; Veronique L Roger; Jill Killian; Susan A Weston; Jonathan Graff-Radford; Samuel J Asirvatham; Alanna M Chamberlain Journal: Mayo Clin Proc Date: 2018-01-09 Impact factor: 7.616
Authors: Ashkan Shoamanesh; Lesly A Pearce; Carlos Bazan; Luciana Catanese; Leslie A McClure; Mukul Sharma; Joan Marti-Fabregas; David C Anderson; Carlos S Kase; Robert G Hart; Oscar R Benavente Journal: Ann Neurol Date: 2017-07-19 Impact factor: 10.422
Authors: Shamir Haji; Ryan Planchard; Adeel Zubair; Jonathan Graff-Radford; Charlotte Rydberg; Robert D Brown; Kelly D Flemming Journal: J Neurol Date: 2015-11-14 Impact factor: 4.849
Authors: Andreas Charidimou; Sara Shams; Jose R Romero; Jie Ding; Roland Veltkamp; Solveig Horstmann; Gudny Eiriksdottir; Mark A van Buchem; Vilmundur Gudnason; Jayandra J Himali; M Edip Gurol; Anand Viswanathan; Toshio Imaizumi; Meike W Vernooij; Sudha Seshadri; Steven M Greenberg; Oscar R Benavente; Lenore J Launer; Ashkan Shoamanesh Journal: Int J Stroke Date: 2018-01-17 Impact factor: 5.266
Authors: Ashkan Shoamanesh; Andrea Morotti; Javier M Romero; Jamary Oliveira-Filho; Frieder Schlunk; Michael J Jessel; Alison M Ayres; Anastasia Vashkevich; Kristin Schwab; Mohammad R Afzal; Christy Cassarly; Renee H Martin; Adnan I Qureshi; Steven M Greenberg; Jonathan Rosand; Joshua N Goldstein Journal: JAMA Neurol Date: 2018-07-01 Impact factor: 18.302
Authors: Richa Sharma; Kunihiro Matsushita; Aozhou Wu; Clifford R Jack; Michael Griswold; Thomas H Mosley; Myriam Fornage; Rebecca F Gottesman Journal: J Am Heart Assoc Date: 2021-02-15 Impact factor: 5.501